Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1)
Hege O. Ohnstad(Oslo University Hospital), Bjørn Naume(Norwegian Cancer Society), Ragnhild Sørum Falk(Oslo University Hospital), Cecilie E. Kiserud(Oslo University Hospital), Bård Mannsåker(Nordland Hospital), Jan F. Nygård(Cancer Registry of Norway), Oluf Dimitri Røe(Norwegian University of Science and Technology), Kristin V. Reinertsen(Oslo University Hospital), HG Russnes(Oslo University Hospital), Jürgen Geisler(Oslo University Hospital), Alina Carmen Porojnicu(Norwegian Cancer Society), Vessela N. Kristensen(University of Oslo), Gry Aarum Geitvik(Oslo University Hospital), Per‐Erik Olsson(Örebro University), Anette Heie(Haukeland University Hospital), Elisabet Sánchez(Privatsykehuset Haugesund), Pål Suhrke(Sykehuset i Vestfold), Helle Kristine Skjerven(Vestre Viken Hospital Trust), Michael Hansen(University Hospital of North Norway), Olav Engebraaten(Oslo University Hospital), Thérese Sørlie(Norwegian Cancer Society), Elin Borgen(Oslo University Hospital), Bjørnar Gilje(Stavanger University Hospital), Tove Nakken(Oslo University Hospital), Jon Lømo(Oslo University Hospital), Lars A. Akslen(University of Bergen), Sunil Xavier Raj(St Olav's University Hospital), Torgunn Kursetgjerde(Sahlgrenska University Hospital), Lars Asphaug(Oslo University Hospital), M. Lyngra(Akershus University Hospital), Jaroslav Bublevič(Helse Førde), Berit Gravdehaug(Akershus University Hospital), E.H. Halset(Oslo University Hospital), H Søiland(Stavanger University Hospital), Beate Boge(Hospital of Southern Norway), M.C. Rypdal(Oslo University Hospital), Silje Songe-Møller(University Hospital of North Norway), Magdalena A Vestlid(Telemark Hospital), Egil Støre Blix(University Hospital of North Norway), Ellen Schlichting(Oslo University Hospital), Anita Langerød(Oslo University Hospital), Oslo Garred(Oslo University Hospital), E. Mortensen(University Hospital of North Norway), Mette Brekke(St Olav's University Hospital), Emiel A. M. Janssen(Stavanger University Hospital)
Cited by 14
Related Papers
The Life History of 21 Breast Cancers
|Cell|2012|1.5k
Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
|Clinical Cancer Research|2009|310
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
|JNCI Journal of the National Cancer Institute|2018|282